| 1 |
Canévet M, Pruvost-Couvreur M, Morvan M, Badic B, Brousse-Potocki J, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Reboux N, Quénéhervé L. Sensitivity of fecal immunochemical test and risk factors for interval colorectal cancer in a French population. Clin Res Hepatol Gastroenterol 2023;47:102093. [PMID: 36764389 DOI: 10.1016/j.clinre.2023.102093] [Reference Citation Analysis]
|
| 2 |
Petersen MM, Kleif J, Jørgensen LN, Hendel JW, Seidelin JB, Madsen MR, Vilandt J, Brandsborg S, Rasmussen JS, Andersen LM, Khalid A, Ferm L, Gawel SH, Martens F, Andersen B, Rasmussen M, Davis GJ, Christensen IJ, Therkildsen C. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden. Clin Colorectal Cancer 2023:S1533-0028(23)00006-3. [PMID: 36878807 DOI: 10.1016/j.clcc.2023.02.001] [Reference Citation Analysis]
|
| 3 |
Tran TN, Hoeck S, De Schutter H, Janssens S, Peeters M, Van Hal G. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study. Int J Environ Res Public Health 2023;20. [PMID: 36674409 DOI: 10.3390/ijerph20021654] [Reference Citation Analysis]
|
| 4 |
Yaghoobi M, Mehraban Far P, Mbuagbaw L, Yuan Y, Armstrong D, Thabane L, Moayyedi P. Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis. Middle East J Dig Dis 2022;14:382-395. [DOI: 10.34172/mejdd.2022.299] [Reference Citation Analysis]
|
| 5 |
Monahan KJ, Davies MM, Abulafi M, Banerjea A, Nicholson BD, Arasaradnam R, Barker N, Benton S, Booth R, Burling D, Carten RV, D'Souza N, East JE, Kleijnen J, Machesney M, Pettman M, Pipe J, Saker L, Sharp L, Stephenson J, Steele RJ. Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG). Gut 2022;71:1939-62. [PMID: 35820780 DOI: 10.1136/gutjnl-2022-327985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 6 |
Świtalski J, Tatara T, Wnuk K, Miazga W, Karauda D, Matera A, Jabłońska M, Jopek S, Religioni U, Gujski M. Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer-An Umbrella Review. Cancers (Basel) 2022;14:4391. [PMID: 36139551 DOI: 10.3390/cancers14184391] [Reference Citation Analysis]
|
| 7 |
Wang L, Chen H, Zhu Y, Lu M, Wang Y, Chen X, Ma W, Du L, Chen W. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China. BMJ Open 2022;12:e059754. [PMID: 35589365 DOI: 10.1136/bmjopen-2021-059754] [Reference Citation Analysis]
|
| 8 |
Morales-arraez D, Hernández A, Hernández-bustabad A, Amaral C, Reygosa C, Nicolás-pérez D, Gimeno-garcía AZ, Hernández-guerra M. Appropriateness of high-priority criteria and safety of endoscopy procedures during the COVID-19 lockdown. PLoS ONE 2022;17:e0267112. [DOI: 10.1371/journal.pone.0267112] [Reference Citation Analysis]
|
| 9 |
Lu B, Wang L, Lu M, Zhang Y, Cai J, Luo C, Chen H, Dai M. Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application. Front Oncol 2022;12:883401. [DOI: 10.3389/fonc.2022.883401] [Reference Citation Analysis]
|
| 10 |
Burke CA, Lieberman D, Feuerstein JD. AGA Clinical Practice Update on Approach to the Use of Noninvasive Colorectal Cancer Screening Options: Commentary. Gastroenterology 2022;162:952-6. [PMID: 35094786 DOI: 10.1053/j.gastro.2021.09.075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Tran TN, Peeters M, Hoeck S, Van Hal G, Janssens S, De Schutter H. Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective. Br J Cancer. [DOI: 10.1038/s41416-021-01694-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Helsingen LM, Kalager M. Colorectal Cancer Screening — Approach, Evidence, and Future Directions. NEJM Evidence 2022;1. [DOI: 10.1056/evidra2100035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Mcferran E, O’mahony JF, Naber S, Sharp L, Zauber AG, Lansdorp-vogelaar I, Kee F. Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals? MDM Policy & Practice 2022;7:238146832210970. [DOI: 10.1177/23814683221097064] [Reference Citation Analysis]
|
| 14 |
Laszlo HE, Seward E, Ayling RM, Lake J, Malhi A, Stephens C, Pritchard-Jones K, Chung D, Hackshaw A, Machesney M. Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review. Br J Cancer 2021. [PMID: 34903843 DOI: 10.1038/s41416-021-01653-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
van Wifferen F, de Jonge L, Worthington J, Greuter MJ, Lew J, Nadeau C, van den Puttelaar R, Feletto E, Yong JH, Lansdorp-vogelaar I, Canfell K, Coupé VM, Anderson L, Besó Delgado M, Binefa G, Cust A, Dekker E, Dell’anna V, Essue B, Espinas J, Flander L, Garcia M, Hahn A, Idigoras I, Katanoda K, Laghi L, Lamrock F, Mcferran E, Majek O, Molina-barceló A, Ledger M, Musa O, Njor S, O’connor K, Portillo I, Salas D, Senore C, Smith H, Symonds E, Tachecí I, Taksler G, Tolani M, Treby M, Zauber A, Zheng Y; on behalf of the COVID-19 and Cancer Global Modelling Consortium (CCGMC) working group 2. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. J Med Screen. [DOI: 10.1177/09691413211056777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Yang Y, Du L, Shi D, Kong C, Liu J, Liu G, Li X, Ma Y. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat Commun 2021;12:6757. [PMID: 34799562 DOI: 10.1038/s41467-021-27112-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 17 |
Zou J, Xiao Z, Wu Y, Yang J, Cui N. Noninvasive fecal testing for colorectal cancer. Clin Chim Acta 2021:S0009-8981(21)00374-0. [PMID: 34756863 DOI: 10.1016/j.cca.2021.10.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Pin-Vieito N, Puga M, Fernández-de-Castro D, Cubiella J. Faecal immunochemical test outside colorectal cancer screening? World J Gastroenterol 2021; 27(38): 6415-6429 [PMID: 34720531 DOI: 10.3748/wjg.v27.i38.6415] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Bretagne JF, Carlo A, Piette C, Rousseau C, Cosson M, Lièvre A. Significant decrease in interval colorectal cancer incidence after implementing immunochemical testing in a multiple-round guaiac-based screening programme. Br J Cancer 2021;125:1494-502. [PMID: 34511603 DOI: 10.1038/s41416-021-01546-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Young GP, Woodman RJ, Symonds E. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. BMJ Open Gastroenterol 2020;7:e000517. [PMID: 32994195 DOI: 10.1136/bmjgast-2020-000517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 21 |
Almilaji O, Smith C, Surgenor S, Clegg A, Williams E, Thomas P, Snook J. Refinement and validation of the IDIOM score for predicting the risk of gastrointestinal cancer in iron deficiency anaemia. BMJ Open Gastroenterol 2020;7:e000403. [PMID: 32444424 DOI: 10.1136/bmjgast-2020-000403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 22 |
Gies A, Niedermaier T, Alwers E, Hielscher T, Weigl K, Heisser T, Schrotz-King P, Hoffmeister M, Brenner H. Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening. Cancers (Basel) 2021;13:3574. [PMID: 34298786 DOI: 10.3390/cancers13143574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Vanaclocha-Espi M, Ibáñez J, Molina-Barceló A, Valverde-Roig MJ, Nolasco A, Pérez-Riquelme F, de la Vega M, Portillo I, Salas D. Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex. PLoS One 2021;16:e0254021. [PMID: 34270590 DOI: 10.1371/journal.pone.0254021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Clark GRC, Strachan JA, McPherson A, Digby J, Mowat C, Steele RJC, Fraser CG. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med 2020;58:2073-80. [PMID: 32324157 DOI: 10.1515/cclm-2020-0268] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 25 |
Cheng WC, Chen PJ, Kang JW, Chen WY, Sheu BS. Age, male sex, smoking and metabolic syndrome as risk factors of advanced colorectal neoplasia for fecal immunochemical test negative patients. J Formos Med Assoc 2021:S0929-6646(21)00240-0. [PMID: 34127350 DOI: 10.1016/j.jfma.2021.05.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Hijos-Mallada G, Lué A, Velamazan R, Saura N, Abril C, Lorenzo M, Navarro M, Chueca E, Arechavaleta S, Gomollón F, Lanas Á, Sostres C. The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort. Front Med (Lausanne) 2021;8:665786. [PMID: 34150803 DOI: 10.3389/fmed.2021.665786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Kim SY, Kim HS, Kim YT, Lee JK, Park HJ, Kim HM, Kang DR. Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study. Clin Transl Gastroenterol 2021;12:e00350. [PMID: 33928919 DOI: 10.14309/ctg.0000000000000350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Hultcrantz R. Aspects of colorectal cancer screening, methods, age and gender. J Intern Med 2021;289:493-507. [PMID: 32929813 DOI: 10.1111/joim.13171] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 29 |
Ferlizza E, Solmi R, Sgarzi M, Ricciardiello L, Lauriola M. The Roadmap of Colorectal Cancer Screening. Cancers (Basel) 2021;13:1101. [PMID: 33806465 DOI: 10.3390/cancers13051101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 30 |
Pallesen AVJ, Herrstedt J, Westendorp RGJ, Mortensen LH, Kristiansen M. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study. Acta Oncol 2021;60:323-32. [PMID: 33427545 DOI: 10.1080/0284186X.2020.1869829] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Pin-Vieito N, García Nimo L, Bujanda L, Román Alonso B, Gutierrez-Stampa MÁ, Aguilar-Gama V, Portillo I, Cubiella J. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. United European Gastroenterol J 2021;9:256-67. [PMID: 32778002 DOI: 10.1177/2050640620949714] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 32 |
Alexandre L, Chan SSM. Iron deficiency: a modern primer to diagnosis and management. Curr Opin Gastroenterol 2021;37:121-7. [PMID: 33315792 DOI: 10.1097/MOG.0000000000000702] [Reference Citation Analysis]
|
| 33 |
Gies A, Niedermaier T, Gruner LF, Heisser T, Schrotz-King P, Brenner H. Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers. Cancers (Basel) 2021;13:644. [PMID: 33562775 DOI: 10.3390/cancers13040644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Chen HD, Lu M, Zhang YH, Dai M. Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas. Chin Med J (Engl) 2021;134:605-7. [PMID: 33410637 DOI: 10.1097/CM9.0000000000001346] [Reference Citation Analysis]
|
| 35 |
Niedermaier T, Tikk K, Gies A, Bieck S, Brenner H. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location. Clin Gastroenterol Hepatol 2020;18:2920-2928.e6. [PMID: 31988043 DOI: 10.1016/j.cgh.2020.01.025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 36 |
Navarro M, Hijos G, Sostres C, Lué A, Puente-Lanzarote JJ, Carrera-Lasfuentes P, Lanas A. Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance. Front Med (Lausanne) 2020;7:410. [PMID: 32984360 DOI: 10.3389/fmed.2020.00410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 37 |
Robertson DJ, Selby K. Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test. Gastrointest Endosc Clin N Am 2020;30:511-26. [PMID: 32439085 DOI: 10.1016/j.giec.2020.02.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 38 |
Marbet UA. Aktueller Stand des Kolonkarzinomscreenings (Fokus auf Stuhltest). Schweiz Gastroenterol 2020;1:42-50. [DOI: 10.1007/s43472-020-00008-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Guo F, De Brabander I, Francart J, Candeur M, Polus M, Van Eycken L, Brenner H. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme. Br J Cancer 2020;122:1109-17. [PMID: 32066910 DOI: 10.1038/s41416-020-0754-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 40 |
Alexandre L, Manning C, Chan SSM. Prevalence of gastrointestinal malignancy in iron deficiency without anaemia: A systematic review and meta-analysis. Eur J Intern Med 2020;72:27-33. [PMID: 31932190 DOI: 10.1016/j.ejim.2019.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 41 |
Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol 2020;17:773-80. [PMID: 33067592 DOI: 10.1038/s41575-020-00368-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
|
